These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22158031)

  • 21. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.
    Hu J; Liu J; Corey DR
    Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice.
    Zajac MS; Pang TY; Wong N; Weinrich B; Leang LS; Craig JM; Saffery R; Hannan AJ
    Hippocampus; 2010 May; 20(5):621-36. PubMed ID: 19499586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant huntingtin can paradoxically protect neurons from death.
    Zuchner T; Brundin P
    Cell Death Differ; 2008 Mar; 15(3):435-42. PubMed ID: 17975550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
    Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME
    Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From gene to disease; HD gene and Huntington disease].
    Maat-Kievit JA; Losekoot M; Roos RA
    Ned Tijdschr Geneeskd; 2001 Nov; 145(44):2120-3. PubMed ID: 11723754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic mechanisms in Huntington's disease.
    Jones L; Hughes A
    Int Rev Neurobiol; 2011; 98():373-418. PubMed ID: 21907095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Huntington disease. A review].
    Bonilla E
    Invest Clin; 2000 Jun; 41(2):117-41. PubMed ID: 10961047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS.
    Østergaard ME; Southwell AL; Kordasiewicz H; Watt AT; Skotte NH; Doty CN; Vaid K; Villanueva EB; Swayze EE; Bennett CF; Hayden MR; Seth PP
    Nucleic Acids Res; 2013 Nov; 41(21):9634-50. PubMed ID: 23963702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA.
    Hu J; Matsui M; Corey DR
    Ann N Y Acad Sci; 2009 Sep; 1175():24-31. PubMed ID: 19796074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression.
    Liu J; Pendergraff H; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Hu J; Corey DR
    Nucleic Acids Res; 2013 Oct; 41(18):8788-801. PubMed ID: 23887934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease models.
    Conroy F; Miller R; Alterman JF; Hassler MR; Echeverria D; Godinho BMDC; Knox EG; Sapp E; Sousa J; Yamada K; Mahmood F; Boudi A; Kegel-Gleason K; DiFiglia M; Aronin N; Khvorova A; Pfister EL
    Nat Commun; 2022 Oct; 13(1):5802. PubMed ID: 36192390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNAi-based therapies for Huntington's disease: delivery challenges and opportunities.
    Mantha N; Das SK; Das NG
    Ther Deliv; 2012 Sep; 3(9):1061-76. PubMed ID: 23035592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients.
    Skotte NH; Southwell AL; Østergaard ME; Carroll JB; Warby SC; Doty CN; Petoukhov E; Vaid K; Kordasiewicz H; Watt AT; Freier SM; Hung G; Seth PP; Bennett CF; Swayze EE; Hayden MR
    PLoS One; 2014; 9(9):e107434. PubMed ID: 25207939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene dysregulation in Huntington's disease: REST, microRNAs and beyond.
    Johnson R; Buckley NJ
    Neuromolecular Med; 2009; 11(3):183-99. PubMed ID: 19458943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts.
    Fink KD; Deng P; Gutierrez J; Anderson JS; Torrest A; Komarla A; Kalomoiris S; Cary W; Anderson JD; Gruenloh W; Duffy A; Tempkin T; Annett G; Wheelock V; Segal DJ; Nolta JA
    Cell Transplant; 2016; 25(4):677-86. PubMed ID: 26850319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.
    Fiszer A; Olejniczak M; Switonski PM; Wroblewska JP; Wisniewska-Kruk J; Mykowska A; Krzyzosiak WJ
    BMC Mol Biol; 2012 Mar; 13():6. PubMed ID: 22397573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lentiviral-mediated gene transfer of siRNAs for the treatment of Huntington's disease.
    Cambon K; Déglon N
    Methods Mol Biol; 2013; 1010():95-109. PubMed ID: 23754221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression.
    Yu D; Pendergraff H; Liu J; Kordasiewicz HB; Cleveland DW; Swayze EE; Lima WF; Crooke ST; Prakash TP; Corey DR
    Cell; 2012 Aug; 150(5):895-908. PubMed ID: 22939619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells.
    Miller JRC; Pfister EL; Liu W; Andre R; Träger U; Kennington LA; Lo K; Dijkstra S; Macdonald D; Ostroff G; Aronin N; Tabrizi SJ
    Sci Rep; 2017 Apr; 7():46740. PubMed ID: 28436437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.